Skip to content

Co-Diagnostics to launch respiratory virus panel

September 1, 2020

Ahead of the flu season and in response to the ongoing coronavirus pandemic, Co-Diagnostics (CODX -0.6%) will launch a new respiratory virus panel designed to test and differentiate influenza A, influenza B and COVID-19.

The company says demand for its RT-PCR tests like Logix Smart COVID-19 remains “significant.”

The stock was one of the top pandemic-related gainers before the recent sell-off. Shares rocketed almost 35-fold from the end of 2019 to a high of $30.99 on August 3. The stock is now exchanging hands at $10.92, down 65% since then.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: